We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genetic Basis Found for a Type of Arrhythmia

By Biotechdaily staff writers
Posted on 17 Feb 2003
Researchers have found that a type of cardiac arrhythmia is due to the abnormal coordination of multiple functionally related ion channels and transporters, caused by a mutation in the gene for the protein ankyrin-B. More...
Their findings were published in the February 6, 2003, issue of Nature.

By studying a French family with the Type 4 form of inherited Long QT Syndrome (LQTS) and performing experiments in mice, investigators from Duke University (Durham, NC, USA) located a mutation in the gene encoding ankyrin-B, a protein found within heart muscle cells.

Comparison of findings from humans with LQTS with those from mice with the E1425G mutation of ankyrin-B showed striking similarities in cardiac performance, including reduced heart rate, a high degree of heart rate variability, and other heart rate disturbances that could not be linked to electrolyte or structural defects of the hearts.

"We found that two normal copies of the ankyrin-B gene are necessary for normal calcium signaling, and that the E1425G mutation leads to a loss of function, explained first author Dr. Peter Mohler, post-doctoral fellow at Duke University. "So, ankyrin-B is the first identified protein implicated in a congenital LQTS that is not an ion channel.”



Related Links:
Duke University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.